Abound Wealth Management Ligand Pharmaceuticals Inc Transaction History
Abound Wealth Management
- $312 Billion
- Q4 2024
A detailed history of Abound Wealth Management transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Abound Wealth Management holds 2 shares of LGND stock, worth $222. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2
Previous 2
-0.0%
Holding current value
$222
Previous $201,000
6.97%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding LGND
# of Institutions
269Shares Held
18.4MCall Options Held
26.8KPut Options Held
9.3K-
Black Rock Inc. New York, NY2.87MShares$320 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.09MShares$232 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X01.01MShares$112 Million0.05% of portfolio
-
Macquarie Group LTD Australia, C3887KShares$98.8 Million0.1% of portfolio
-
Dimensional Fund Advisors LP Austin, TX723KShares$80.5 Million0.02% of portfolio
About LIGAND PHARMACEUTICALS INC
- Ticker LGND
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 16,882,800
- Market Cap $1.88B
- Description
- Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...